SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
NYMX
--
0.00%
--
Nymox Pharma Offers Update On Current Developments
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report current updates on the Company's most important ongoing developments. The Company reports further significant and important progress has been made
Benzinga · 5d ago
NYMOX Provides Current Update on Key Company Developments
HASBROUCK HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report current updates on the Company's most important ongoing developments. The Company reports further significant and important progress
GlobeNewswire · 5d ago
Nymox Pharmaceutical Entered Into Sales Agreement With Alliance Global Partners As Sales Agent
Benzinga · 07/20 20:25
Nymox (+8%) on track to file fexapotide applications in ~four months
Seeking Alpha - Article · 06/19 15:54
Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
GlobeNewswire · 06/19 14:30
Nymox Pharma Offers Update On Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track. The majority of its regulatory
Benzinga · 06/19 13:31
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16)
Benzinga · 06/16 12:15
Hedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)
Insider Monkey · 06/05 20:16
If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
Simply Wall St. · 05/05 14:08
Nymox Announces Important New Patent Developments
GlobeNewswire · 04/21 13:45
Nymox Pharmaceutical Corp Files For Mixed Shelf Offering Of Up To $12M
-Reuters
Reuters · 04/03 17:54
Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?
Simply Wall St. · 03/21 15:10
Nymox Pharma Highlights New Peer Review Publication Of Its Prostate Cancer Candidate Fexapotide In World Journal Of Urology
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that a new peer review report was published today in the World Journal of Urology, documenting the successful long-term clinical trial results after
Benzinga · 02/24 14:31
Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
GlobeNewswire · 02/24 14:30
Nymox Pharmaceutical: Employee Resume Substantiates Concerns
Seeking Alpha - Article · 02/20 16:00
Nymox Pharmaceuticals Has A Long History Of Broken Promises And Baffling Delays That Will Likely Continue
Seeking Alpha - Article · 02/06 15:00
Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
GlobeNewswire · 02/06 14:30
Is Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
Simply Wall St. · 02/05 15:32
Nymox Pharma Offers Corporate, Milestone Update
 Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to provide a current January 2020 update on several important corporate activities and achievements since the last update in October 2019. The Company
Benzinga · 01/28 14:32
Nymox Provides Update on Current Corporate Activities and Milestones
GlobeNewswire · 01/28 14:30